InvestorsHub Logo
icon url

Testpilot

08/11/22 6:52 PM

#40129 RE: twaflyer1 #40128

TWA,

TP., I don't think u got the gest of what I was saying? I and some others who have been here for quite a while, have seen this Co' who had a great opportunity in licensing the CHS technology from NDSU, but couldn't follow through!

I had high hopes, but Krafty, who had a great payment deal with Coretec, muffed it for me! My hopes were dashed to below zero, because the longer I became an Investor, the more I didn't like about him! His talk convinced me, unfortunately!



I believe I did get the gist of what you were posting. However, you come across as being stuck in the past on the NDSU deal. Quikshft and I have been in 3Dicon (TDCP) since 2005/2006, and went through the 300 to 1 RS that facilitated the merger of 3DIcon with Coretec. Gelest attempted to scale the CHS chemical compound according to the NDSU patent. It just didn't work. So, Michael K and Ramez E came up with another chemical compound for CHS, which is patented, that Evonik was able to scale by 100 times. Now Victor Keen, an insider, bought one 1 million shares in the last 2 weeks, and it looks like RCI is working things out with CRTG. It might be a good time wake up and smell the coffee
icon url

Quikshft

08/12/22 12:48 AM

#40132 RE: twaflyer1 #40128

"As you know, Coretec’s introduction to CHS began as a licensee from North Dakota State University (“NDSU”). Our goal for licensing CHS technology was to secure a process for manufacturing CHS. However, after significant efforts over more than two years, we determined that the NDSU CHS synthesis process could not be scaled up (i.e. the process was not commercially viable) and, accordingly, we terminated the NDSU relationship".